BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu H, Cai Y, Zhang Y, Xie Y, Qiu H, Hua L, Liu X, Li Y, Lu J, Zhang L, Yu R. Development of a Hypoxic Radiosensitizer-Prodrug Liposome Delivery DNA Repair Inhibitor Dbait Combination with Radiotherapy for Glioma Therapy. Adv Healthc Mater 2017;6. [PMID: 28371526 DOI: 10.1002/adhm.201601377] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Sun I, Yoon HY, Lim D, Kim K. Recent Trends in In Situ Enzyme-Activatable Prodrugs for Targeted Cancer Therapy. Bioconjugate Chem 2020;31:1012-24. [DOI: 10.1021/acs.bioconjchem.0c00082] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
2 Jiao X, Yu Y, Meng J, He M, Zhang CJ, Geng W, Ding B, Wang Z, Ding X. Dual-targeting and microenvironment-responsive micelles as a gene delivery system to improve the sensitivity of glioma to radiotherapy. Acta Pharm Sin B 2019;9:381-96. [PMID: 30972284 DOI: 10.1016/j.apsb.2018.12.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
3 Chen J, Dong H, Bai L, Li L, Chen S, Tian X, Pan Y. Multifunctional high-Z nanoradiosensitizers for multimodal synergistic cancer therapy. J Mater Chem B 2022;10:1328-42. [PMID: 35018941 DOI: 10.1039/d1tb02524d] [Reference Citation Analysis]
4 Zhou M, Xie Y, Xu S, Xin J, Wang J, Han T, Ting R, Zhang J, An F. Hypoxia-activated nanomedicines for effective cancer therapy. Eur J Med Chem 2020;195:112274. [PMID: 32259703 DOI: 10.1016/j.ejmech.2020.112274] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
5 Zhao YN, Cao YN, Sun J, Liang Z, Wu Q, Cui SH, Zhi DF, Guo ST, Zhen YH, Zhang SB. Anti-breast cancer activity of resveratrol encapsulated in liposomes. J Mater Chem B 2020;8:27-37. [PMID: 31746932 DOI: 10.1039/c9tb02051a] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 4.7] [Reference Citation Analysis]
6 Duan Z, Luo Q, Gu L, Li X, Zhu H, Gu Z, Gong Q, Zhang H, Luo K. A co-delivery nanoplatform for a lignan-derived compound and perfluorocarbon tuning IL-25 secretion and the oxygen level in tumor microenvironments for meliorative tumor radiotherapy. Nanoscale 2021;13:13681-92. [PMID: 34477643 DOI: 10.1039/d1nr03738b] [Reference Citation Analysis]
7 Hua L, Wang Z, Zhao L, Mao H, Wang G, Zhang K, Liu X, Wu D, Zheng Y, Lu J, Yu R, Liu H. Hypoxia-responsive lipid-poly-(hypoxic radiosensitized polyprodrug) nanoparticles for glioma chemo- and radiotherapy. Theranostics 2018;8:5088-105. [PMID: 30429888 DOI: 10.7150/thno.26225] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 9.8] [Reference Citation Analysis]
8 Xie Y, Han Y, Zhang X, Ma H, Li L, Yu R, Liu H. Application of New Radiosensitizer Based on Nano-Biotechnology in the Treatment of Glioma. Front Oncol 2021;11:633827. [PMID: 33869019 DOI: 10.3389/fonc.2021.633827] [Reference Citation Analysis]
9 Lu H, Yang Y, Lin X, Shi P, Shen Y. Low-Invasive Cell Injection based on Rotational Microrobot. Adv Biosyst 2019;3:e1800274. [PMID: 32648674 DOI: 10.1002/adbi.201800274] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Mao H, Xie Y, Ju H, Mao H, Zhao L, Wang Z, Hua L, Zhao C, Li Y, Yu R, Liu H. Design of Tumor Microenvironment-Responsive Drug–Drug Micelle for Cancer Radiochemotherapy. ACS Appl Mater Interfaces 2018;10:33923-35. [DOI: 10.1021/acsami.8b11159] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
11 Zeng Q, Jiang B, Shi F, Ling C, Dong F, Zhang J. 3D Pseudocontinuous Arterial Spin-Labeling MR Imaging in the Preoperative Evaluation of Gliomas. AJNR Am J Neuroradiol 2017;38:1876-83. [PMID: 28729293 DOI: 10.3174/ajnr.A5299] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
12 Zhao Z, Shen J, Zhang L, Wang L, Xu H, Han Y, Jia J, Lu Y, Yu R, Liu H. Injectable postoperative enzyme-responsive hydrogels for reversing temozolomide resistance and reducing local recurrence after glioma operation. Biomater Sci 2020;8:5306-16. [PMID: 32573615 DOI: 10.1039/d0bm00338g] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]